Percentage of end stage renal disease (ESRD) patients aged 6 months and older receiving hemodialysis or peritoneal dialysis during the time from October 1 (or when the influenza vaccine became available) to March 31 who either received, were offered and declined, or were determined to have a medical contraindication to the influenza vaccine.
- Measure TypeElectronic Clinical Quality Measure (eCQM)Level Of AnalysisCare SettingNumerator
Number of patients from the denominator who:
1. received an influenza vaccination,* documented by the provider or reported receipt from another provider by the patient (computed and reported separately);
OR
2. were assessed and offered an influenza vaccination but declined (computed and reported separately);
OR
3. were assessed and determined to have a medical contraindication(s) of anaphylactic hypersensitivity to eggs or other component(s) of the vaccine, history of Guillain-Barre Syndrome within 6 weeks after a previous influenza vaccination, and/or bone marrow transplant within the past 6 months (<6 months prior to encounters between October 1 and March 31) (computed and reported separately).
*Only inactivated vaccine should be used in the ESRD population.DenominatorAll ESRD patients aged 6 months and older receiving hemodialysis and/or peritoneal dialysis during the time from October 1 (or when the influenza vaccine became available) to March 31.
ExclusionsNone.
Testing Data Sources
- Measure StructureClinical Condition Topic AreaNon Condition SpecificTarget PopulationMeasure Selection AttributesNational Quality Strategy PrioritiesHealth and Well-Being
- Risk Adjustment
- Most Recent Endorsement ActivityMeasure Retired and Endorsement Removed Health and Well Being Project 2015-2017Initial EndorsementEndorsement StatusLast UpdatedRemoval Date
- StewardSteward Organization EmailSteward Organization Copyright
© 2016 Kidney Care Quality Alliance. All Rights Reserved.